CI - Cigna Corporation

NYSE - NYSE Delayed Price. Currency in USD
171.73
-3.48 (-1.99%)
At close: 4:03PM EDT

171.73 -0.10 (-0.06%)
After hours: 4:12PM EDT

Stock chart is not supported by your current browser
Previous Close175.21
Open174.56
Bid171.74 x 100
Ask171.74 x 5900
Day's Range171.46 - 174.62
52 Week Range151.04 - 227.13
Volume1,910,697
Avg. Volume2,621,337
Market Cap41.771B
Beta0.56
PE Ratio (TTM)19.58
EPS (TTM)8.77
Earnings DateMay 3, 2018
Forward Dividend & Yield0.04 (0.02%)
Ex-Dividend Date2018-03-09
1y Target Est222.22
Trade prices are not sourced from all markets
  • Cigna-Express Scripts Deal to Face Justice Department Review
    Bloomberg22 hours ago

    Cigna-Express Scripts Deal to Face Justice Department Review

    Cigna Corp. confirmed that its proposed $54 billion acquisition of Express Scripts Holding Co. will be reviewed by the U.S. Department of Justice, which has raised the bar for approving deals that don’t combine direct competitors. Analysts at Credit Suisse sent an alert to clients on April 5, saying Cigna Chief Executive Officer David Cordani told investors during an event in Europe that the deal would be looked at by the Justice Department. Cigna agreed in March to acquire Express Scripts, a pharmacy-benefits manager, wagering that the combination can reduce costs and improve benefits for Americans by simplifying the health-care supply chain.

  • Moody's2 days ago

    Moody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare

    In its latest issue of Healthcare Quarterly, Moody's Investors Service examines how planned mergers between health insurers and other healthcare companies, as well as potential new entrants to the US healthcare ...

  • InvestorPlace2 days ago

    UnitedHealth Group Inc Stock: Wall Street’s Biggest Moat

    UnitedHealth Group Inc (NYSE:UNH), the giant health insurer, beat the street on April 17 and raised estimates, illustrating its dominance in the healthcare space. The company earned $2.924 billion, $3.04-per-share fully adjusted, on revenues of $55.188 billion. This handily beat estimates for $2.92-per-share of earnings, and whispers of $2.97-per-share, on revenues of $54.85 billion. The stock rose to $6.04-per-share, 2.69%, in anticipation of earnings, and added another $4.19, 1.82%, in pre-market trading.

  • UnitedHealth Group beats on Q1 earnings, Netflix surges, new details of Walmart’s new site
    Yahoo Finance Video2 days ago

    UnitedHealth Group beats on Q1 earnings, Netflix surges, new details of Walmart’s new site

    UnitedHealth Group, Netflix, Walmart, Tesla and Comerica are the companies to watch.

  • How Is UNH’s Optum Business Positioned in the Industry?
    Market Realist2 days ago

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world. Its subsidiaries, UnitedHealthcare and Optum, offer health insurance services and healthcare products.

  • Earnings Expectations for UnitedHealth Group in 1Q18
    Market Realist3 days ago

    Earnings Expectations for UnitedHealth Group in 1Q18

    On April 17, 2018, UnitedHealth Group (UNH) is set to announce its fiscal 1Q18 earnings. Wall Street expects UnitedHealth Group to register adjusted EPS (earnings per share) of ~$2.91, representing ~22.7% growth YoY (year-over-year). In fiscal 4Q17, the company reported adjusted EPS of ~$2.59, representing ~22.8% YoY growth.

  • Could UnitedHealth Group Beat Analysts’ Revenue Estimates Again?
    Market Realist3 days ago

    Could UnitedHealth Group Beat Analysts’ Revenue Estimates Again?

    On April 17, 2018, UnitedHealth Group (UNH) is set to announce its 1Q18 earnings results. In fiscal 1Q18, UnitedHealth Group’s sales are expected to grow 12.5% YoY (year-over-year) to $54.8 billion. In 4Q17, the company registered sales of $52 billion, representing ~9.6% YoY growth, beatings analysts’ estimates. In fiscal 3Q17, the company missed analysts’ estimates.

  • Business Wire14 days ago

    Cigna Corporation’s First Quarter 2018 Earnings Release Details

    Cigna Corporation will release its First Quarter 2018 financial results on Thursday, May 3, 2018 and will host a conference call on the same day.

  • Moody's14 days ago

    Moody's: Cost control main benefit of industry-shifting vertical integration for US health insurers

    The trend of health insurers seeking to expand vertically through mergers and acquisitions to pharmacy benefits and point-of-care service has continued apace for several years, and with several large deals ...

  • America’s Favorite TV Doctors of America Are Now On-Call
    Business Wire14 days ago

    America’s Favorite TV Doctors of America Are Now On-Call

    With a mission to save 100,000 lives by encouraging Americans to get their annual check-upi, global health service company Cigna has reunited the stars of its TV Doctors of America campaign to give Americans personalized, mobile reminders to schedule their annual check-ups.

  • The Wall Street Journal15 days ago

    Express Scripts Appoints New CIO from Farmers Insurance

    Ron Guerrier, who led the creation of Toyota’s innovation lab before serving as CIO at Farmers Insurance, joins Express Scripts amid the company’s sale to health insurer Cigna.

  • CNBC15 days ago

    Global M&A activity hits record high on mega US health care deals

    Merger and acquisition (M&A) activity across the world has hit a seventeen-year-record high in the first quarter of 2018, according to a report by research firm Mergermarket.

  • Forbes15 days ago

    Final Obamacare Tally Shows 12M Despite Trump's Marketing Squeeze

    Nearly 12 million Americans enrolled in coverage via exchanges under the Affordable Care Act despite a narrower sign-up window and cuts to marketing implemented by the Donald Trump administration.

  • Business Wire16 days ago

    Glancy Prongay & Murray LLP Announces Investigation on Behalf of Cigna Corporation Investors (CI)

    Glancy Prongay & Murray LLP announces an investigation on behalf of Cigna Corporation  investors concerning the Company and its directors’ and officers’ possible violations of state laws.

  • Barrons.com16 days ago

    [$$] Buyout Target Express Scripts Has 30%-Plus Upside

    • Recent price: $67.87 • Target price: $89.58 • Timeframe: 6-12 months The Opportunity: On March 8, 2018, health insurer Cigna Corporation (CI) announced that it had entered into an agreement to acquire pharmacy benefit manager Express Scripts Holding Company (ESRX) in a $67-billion stock and cash transaction. Financing for the transaction has been committed and the transaction is expected to close by year-end. At current prices, the deal spread has widened to approximately 30% and Express Scripts trades below where it did prior to the deal announcement.

  • Walmart Eyes Growth Avenues—Healthcare Could Be One
    Market Realist16 days ago

    Walmart Eyes Growth Avenues—Healthcare Could Be One

    CNBC has reported that Walmart (WMT) is looking to acquire PillPack, an online pharmacy startup, for less than $1 billion. If the deal goes through, PillPack will help Walmart expand its pharmacy offerings, making Walmart more relevant to those customers—primarily senior citizens—who are using multiple medications. This comes amid reports that Walmart is looking for closer ties to or a merger with Humana (HUM).

  • Benzinga19 days ago

    Leerink's Takeaways From CNBC's 'Healthy Returns' Conference

    The CNBC Healthy Returns Conference recently came to an end, and Leerink analyst Ana Gupte summarized the key takeaways from the event in a note on Thursday. Here’s what investors need to know: According ...

  • Moody's22 days ago

    CareCentrix, Inc. -- Moody's affirms CareCentrix's B1 ratings; changes outlook to stable

    Moody's Investors Service, ("Moody's") affirmed CareCentrix Inc.'s ("CareCentrix") B1 Corporate Family Rating (CFR), B1-PD Probability of Default Rating (PDR) and B1 first lien credit ...

  • TheStreet.com22 days ago

    Cigna Facing More Declines

    Dead cross looming in charts of Cigna.

  • Reuters22 days ago

    FDA working on a "dozen" policies to boost copycat biotech drugs

    The U.S. Food & Drug Administration is working on around a dozen actions to boost use of cheaper versions of expensive biotech medicines, the head of the agency Scott Gottlieb said on Wednesday. The United States has lagged behind Europe in use of so-called biosimilars, to the frustration of FDA policymakers who are starting to approve such products but who are seeing other impediments to getting them to consumers. Biological drugs for treating serious conditions such as cancer and rheumatoid arthritis are complex molecules made inside living cells.

  • Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal
    Business Wire22 days ago

    Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal

    Cigna today announced that in partnership with more than 1.1 million prescribing clinicians, the global health service company has achieved a 25 percent reduction in opioid use among its customers, reaching this key metric one year ahead of its ambitious initial goal.

  • Yahoo Finance Live: Midday Movers - Apr 12th, 2018
    Yahoo Finance Video7 days ago

    Yahoo Finance Live: Midday Movers - Apr 12th, 2018

    Yahoo Finance's LIVE stock market coverage and analysis.

  • Yahoo Finance Live: Market Movers - Apr 3rd, 2018
    Yahoo Finance Video16 days ago

    Yahoo Finance Live: Market Movers - Apr 3rd, 2018

    Yahoo Finance's LIVE stock market coverage and analysis.

  • Trump makes a house call to replace Veterans Affairs Secretary
    Yahoo Finance Video21 days ago

    Trump makes a house call to replace Veterans Affairs Secretary

    President Donald Trump is picking his personal physician, Rear Admiral Ronny Jackson, as the new head of Veterans Affairs. Yahoo Finance’s Alexis Christoforous and Editor-in-Chief Andy Serwer examine the details.